NCT07415161

Brief Summary

This randomized clinical trial investigates whether Oxygen Reserve Index (ORi) monitoring enables earlier detection of impending hypoxemia compared with conventional pulse oximetry during apneic intermittent ventilation in adult patients undergoing endolaryngeal surgery under general anesthesia. By providing continuous, noninvasive assessment of oxygen reserve in the hyperoxic range, ORi may offer an earlier warning of oxygen depletion before peripheral oxygen saturation declines. The study compares time to reventilation thresholds, arterial blood gas parameters, and perioperative respiratory outcomes between ORi-guided and standard SpO₂-guided monitoring strategies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 27, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2026

Completed
Last Updated

February 17, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

January 27, 2026

Last Update Submit

February 15, 2026

Conditions

Keywords

oxygen reserve indexpulse oximetryapneic ventilation

Outcome Measures

Primary Outcomes (1)

  • Time to Reventilation Threshold

    Time from the onset of apnea to the predefined reventilation threshold, defined as Oxygen Reserve Index (ORi) reaching zero in the ORi group and peripheral oxygen saturation (SpO₂) decreasing to 90% in the control group, measured in seconds.

    From the onset of apnea until the predefined reventilation threshold is reached during the intraoperative period (within minutes).

Secondary Outcomes (4)

  • Arterial Blood Gas Parameters at Reventilation

    From the onset of apnea until the predefined reventilation threshold is reached during the intraoperative period (within minutes).

  • Perioperative Lung Ultrasound Findings

    Preoperatively (before anesthesia induction) and postoperatively in the post-anesthesia care unit (within 1 hour after surgery).

  • Postoperative Oxygenation

    postoperatively in the post-anesthesia care unit (within 1 hour after surgery).

  • End-Tidal Carbon Dioxide (EtCO₂) Level

    During the apneic period, measured at the time of reventilation during surgery.

Study Arms (2)

Oxygen Reserve Index

EXPERIMENTAL

Participants in this arm will undergo continuous Oxygen Reserve Index (ORi) monitoring in addition to standard anesthesia monitoring during general anesthesia with apneic intermittent ventilation for endolaryngeal surgery. ORi values will be used to guide the timing of reventilation, with reventilation initiated when ORi reaches zero, indicating depletion of oxygen reserve. Standard clinical care and anesthesia management will otherwise be identical to the control group.

Procedure: oxygen monitoring techniques

Peripheral oxygen saturation

NO INTERVENTION

Participants in this arm will receive standard anesthesia monitoring, including continuous peripheral oxygen saturation (SpO₂) monitoring, during general anesthesia with apneic intermittent ventilation for endolaryngeal surgery. The timing of reventilation will be guided by SpO₂ values, with reventilation initiated when SpO₂ decreases to 90%. All other aspects of anesthesia care and perioperative management will be identical to the experimental arm.

Interventions

to determine whether ORi monitoring provides earlier and clinically meaningful warning of oxygen reserve depletion compared with conventional pulse oximetry, potentially improving patient safety during shared-airway surgery.

Oxygen Reserve Index

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Scheduled for elective endolaryngeal surgery
  • Planned general anesthesia with apneic intermittent ventilation
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Ability to provide written informed consent

You may not qualify if:

  • Age under 18 years
  • Preoperative chronic hypoxemia (baseline SpO₂ \< 95%)
  • Patients transferred from the intensive care unit
  • ASA physical status IV or higher
  • Refusal or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University, Department of anesthesiology

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

Related Publications (2)

  • Fleming NW, Singh A, Lee L, Applegate RL 2nd. Oxygen Reserve Index: Utility as an Early Warning for Desaturation in High-Risk Surgical Patients. Anesth Analg. 2021 Mar 1;132(3):770-776. doi: 10.1213/ANE.0000000000005109.

  • Szmuk P, Steiner JW, Olomu PN, Ploski RP, Sessler DI, Ezri T. Oxygen Reserve Index: A Novel Noninvasive Measure of Oxygen Reserve--A Pilot Study. Anesthesiology. 2016 Apr;124(4):779-84. doi: 10.1097/ALN.0000000000001009.

Study Officials

  • ece naz demir, resident

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • demet altun, prof

    Istanbul University

    STUDY DIRECTOR

Central Study Contacts

ece naz demir, resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Masking Description
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Model Description
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 27, 2026

First Posted

February 17, 2026

Study Start

January 27, 2026

Primary Completion

March 15, 2026

Study Completion

March 25, 2026

Last Updated

February 17, 2026

Record last verified: 2026-01

Locations